531 related articles for article (PubMed ID: 11022082)
1. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats.
Nishimura Y; Ito T; Saavedra JM
Stroke; 2000 Oct; 31(10):2478-86. PubMed ID: 11022082
[TBL] [Abstract][Full Text] [Related]
2. The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression.
Nishimura Y; Xu T; Jöhren O; Häuser W; Saavedra JM
Basic Res Cardiol; 1998; 93 Suppl 2():63-8. PubMed ID: 9833166
[TBL] [Abstract][Full Text] [Related]
3. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist.
Ito T; Yamakawa H; Bregonzio C; Terrón JA; Falcón-Neri A; Saavedra JM
Stroke; 2002 Sep; 33(9):2297-303. PubMed ID: 12215602
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment with candesartan protects from cerebral ischaemia.
Ito T; Nishimura Y; Saavedra J
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):174-9. PubMed ID: 11881119
[TBL] [Abstract][Full Text] [Related]
5. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition.
Yamakawa H; Jezova M; Ando H; Saavedra JM
J Cereb Blood Flow Metab; 2003 Mar; 23(3):371-80. PubMed ID: 12621312
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation.
Vraamark T; Waldemar G; Strandgaard S; Paulson OB
J Hypertens; 1995 Jul; 13(7):755-61. PubMed ID: 7594439
[TBL] [Abstract][Full Text] [Related]
7. Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats.
Omura-Matsuoka E; Yagita Y; Sasaki T; Terasaki Y; Oyama N; Sugiyama Y; Okazaki S; Sakoda S; Kitagawa K
Hypertens Res; 2009 Jul; 32(7):548-53. PubMed ID: 19424281
[TBL] [Abstract][Full Text] [Related]
8. Chronic peripheral administration of the angiotensin II AT(1) receptor antagonist candesartan blocks brain AT(1) receptors.
Nishimura Y; Ito T; Hoe K; Saavedra JM
Brain Res; 2000 Jul; 871(1):29-38. PubMed ID: 10882779
[TBL] [Abstract][Full Text] [Related]
9. AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats.
Zhou J; Pavel J; Macova M; Yu ZX; Imboden H; Ge L; Nishioku T; Dou J; Delgiacco E; Saavedra JM
Stroke; 2006 May; 37(5):1271-6. PubMed ID: 16601219
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats.
Ando H; Zhou J; Macova M; Imboden H; Saavedra JM
Stroke; 2004 Jul; 35(7):1726-31. PubMed ID: 15143297
[TBL] [Abstract][Full Text] [Related]
11. Candesartan normalizes exaggerated tubuloglomerular feedback activity in young spontaneously hypertensive rats.
Brännström K; Morsing P; Arendshorst WJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S213-9. PubMed ID: 9892166
[TBL] [Abstract][Full Text] [Related]
12. Potentiated sympathetic nervous and renin-angiotensin systems reduce nonlinear correlation between sympathetic activity and blood pressure in conscious spontaneously hypertensive rats.
Sakata K; Kumagai H; Osaka M; Onami T; Matsuura T; Imai M; Saruta T
Circulation; 2002 Jul; 106(5):620-5. PubMed ID: 12147546
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT( 1 ) Receptor Antagonists in the Brain.
Saavedra JM; Benicky J; Zhou J
Cell Mol Neurobiol; 2006; 26(7-8):1099-111. PubMed ID: 16636899
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats.
Lu Q; Zhu YZ; Wong PT
Neuroreport; 2005 Nov; 16(17):1963-7. PubMed ID: 16272888
[TBL] [Abstract][Full Text] [Related]
15. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.
Engelhorn T; Goerike S; Doerfler A; Okorn C; Forsting M; Heusch G; Schulz R
J Cereb Blood Flow Metab; 2004 Apr; 24(4):467-74. PubMed ID: 15087716
[TBL] [Abstract][Full Text] [Related]
16. Year-long antihypertensive therapy with candesartan completely prevents development of cardiovascular organ injuries in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohno E; Furukata S; Sudo Y; Nakano N; Takahashi T; Ono H; Matsuoka H
Int Heart J; 2010; 51(5):359-64. PubMed ID: 20966610
[TBL] [Abstract][Full Text] [Related]
17. Effect of AT1 receptor blockade on hepatic redox status in SHR: possible relevance for endothelial function?
Cediel E; Sanz-Rosa D; Oubina MP; de las Heras N; González Pacheco FR; Vegazo O; Jiménez J; Cachofeiro V; Lahera V
Am J Physiol Regul Integr Comp Physiol; 2003 Sep; 285(3):R674-81. PubMed ID: 12775556
[TBL] [Abstract][Full Text] [Related]
18. Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice.
Ruan X; Purdy KE; Oliverio MI; Coffman TM; Arendshorst WJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S202-7. PubMed ID: 9892164
[TBL] [Abstract][Full Text] [Related]
19. Cerebral microregional oxygen balance during chronic versus acute hypertension in middle cerebral artery occluded rats.
Chi OZ; Wei HM; Tse J; Klein SL; Weiss HR
Anesth Analg; 1996 Mar; 82(3):587-92. PubMed ID: 8623966
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic oral treatment with imidapril and TCV-116 on the responsiveness to angiotensin II in ventrolateral medulla of SHR.
Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
J Hypertens; 1999 Jul; 17(7):917-22. PubMed ID: 10419064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
